Poll: Type 2 Diabetes Medications
There are many therapeutic options in type 2 diabetes.
Findings accentuate the much greater concern regarding clinical outcomes in participants who did not respond to metformin monotherapy.
For patients with type 2 diabetes, all weight categories show increased long-term mortality, with a nadir at a body mass index of 25 to <30.
Well-constructed and individualized nutrition therapy programs were found to effectively reduce HbA1c and BMI in individuals with type 2 diabetes.